OBJECTIVE: To investigate whether genetic variation at the UCP3 locus contributes to human obesity. SUBJECTS: Ninety-one obese children (BMI>4 standard deviations from age related mean) and 419 Caucasian adults from the Isle of Ely Study. DESIGN: Single strand conformation polymorphism (SSCP) analysis was used to scan the coding region of the UCP3 gene in 91 severely obese children. A common polymorphism identified in this gene (c-55t) has been shown to associate with lower UCP3 mRNA expression. Polymerase chain reaction-based forced restriction digestion was used to detect this allele in Caucasian adults. Multiple regression analysis was used to determine associations between the c-55t genotype and anthropometric, energetic and biochemical indices relevant to obesity. MEASUREMENTS: For the obese children, SSCP analysis and sequencing of variants were carried out. For the Isle of Ely Study, c-55t genotype and anthropometric (body mass index, waist-hip ratio, percentage body fat), energetic (dietary fat intake, physical activity index, adjusted metabolic rate, maximum oxygen consumption) and biochemical indices (pre- and post-glucose challenge plasma triglycerides, non-esterified fatty acids, insulin and glucose) were determined. RESULTS: A previously reported missense mutation (V102I) was detected in a single obese Afro-Carribean child. Twenty-one percent of the genes examined in the Isle of Ely study carried the c-55t promoter variant. Age-adjusted body mass index (BMI) was significantly (P=0.0037) lower in carriers of this variant. CONCLUSION: Mutations in the coding sequence of UCP3 are unlikely to be a common monogenic cause of severe human obesity. In a Caucasian population the UCP3 c-55t polymorphism is negatively associated with BMI.
OBJECTIVE: To investigate whether genetic variation at the UCP3 locus contributes to humanobesity. SUBJECTS: Ninety-one obesechildren (BMI>4 standard deviations from age related mean) and 419 Caucasian adults from the Isle of Ely Study. DESIGN: Single strand conformation polymorphism (SSCP) analysis was used to scan the coding region of the UCP3 gene in 91 severely obesechildren. A common polymorphism identified in this gene (c-55t) has been shown to associate with lower UCP3 mRNA expression. Polymerase chain reaction-based forced restriction digestion was used to detect this allele in Caucasian adults. Multiple regression analysis was used to determine associations between the c-55t genotype and anthropometric, energetic and biochemical indices relevant to obesity. MEASUREMENTS: For the obesechildren, SSCP analysis and sequencing of variants were carried out. For the Isle of Ely Study, c-55t genotype and anthropometric (body mass index, waist-hip ratio, percentage body fat), energetic (dietary fat intake, physical activity index, adjusted metabolic rate, maximum oxygen consumption) and biochemical indices (pre- and post-glucose challenge plasma triglycerides, non-esterified fatty acids, insulin and glucose) were determined. RESULTS: A previously reported missense mutation (V102I) was detected in a single obese Afro-Carribean child. Twenty-one percent of the genes examined in the Isle of Ely study carried the c-55t promoter variant. Age-adjusted body mass index (BMI) was significantly (P=0.0037) lower in carriers of this variant. CONCLUSION: Mutations in the coding sequence of UCP3 are unlikely to be a common monogenic cause of severe humanobesity. In a Caucasian population the UCP3 c-55t polymorphism is negatively associated with BMI.
Authors: E Lapice; A Monticelli; S Cocozza; M Pinelli; A Giacco; A A Rivellese; S Cocozza; G Riccardi; O Vaccaro Journal: Int J Obes (Lond) Date: 2013-09-12 Impact factor: 5.095
Authors: Sukhbir S Dhamrait; Alun G Williams; Stephen H Day; James Skipworth; John R Payne; Michael World; Steve E Humphries; Hugh E Montgomery Journal: J Appl Physiol (1985) Date: 2012-01-12
Authors: Punit Kaur; Michael D Reis; Glen R Couchman; Samuel N Forjuoh; John F Greene; Alexzander Asea Journal: J Proteomics Bioinform Date: 2010-06-01
Authors: Heiko Bugger; Cinthia Guzman; Christoph Zechner; Monica Palmeri; Kerry S Russell; Raymond R Russell Journal: Cancer Chemother Pharmacol Date: 2010-08-31 Impact factor: 3.333
Authors: Ildus I Ahmetov; Alun G Williams; Daniil V Popov; Ekaterina V Lyubaeva; Albina M Hakimullina; Olga N Fedotovskaya; Irina A Mozhayskaya; Olga L Vinogradova; Irina V Astratenkova; Hugh E Montgomery; Viktor A Rogozkin Journal: Hum Genet Date: 2009-12 Impact factor: 4.132
Authors: C V Musa; A Mancini; A Alfieri; G Labruna; G Valerio; A Franzese; F Pasanisi; M R Licenziati; L Sacchetti; P Buono Journal: Int J Obes (Lond) Date: 2011-04-19 Impact factor: 5.095
Authors: Titta Salopuro; Leena Pulkkinen; Jaana Lindström; Marjukka Kolehmainen; Anna-Maija Tolppanen; Johan G Eriksson; Timo T Valle; Sirkka Aunola; Pirjo Ilanne-Parikka; Sirkka Keinänen-Kiukaanniemi; Jaakko Tuomilehto; Markku Laakso; Matti Uusitupa Journal: BMC Med Genet Date: 2009-09-21 Impact factor: 2.103